These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36680436)

  • 41. Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study.
    Underwood M; Horton J; Nangle K; Hopking J; Smith K; Aboud M; Wynne B; Sievers J; Stewart EL; Wang R
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0164321. PubMed ID: 34694877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
    Bareng OT; Moyo S; Zahralban-Steele M; Maruapula D; Ditlhako T; Mokaleng B; Mokgethi P; Choga WT; Moraka NO; Pretorius-Holme M; Mine MO; Raizes E; Molebatsi K; Motswaledi MS; Gobe I; Mohammed T; Gaolathe T; Shapiro R; Mmalane M; Makhema JM; Lockman S; Essex M; Novitsky V; Gaseitsiwe S
    J Antimicrob Chemother; 2022 Apr; 77(5):1385-1395. PubMed ID: 35229102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
    Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
    PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemical analysis of the role of G118R-linked dolutegravir drug resistance substitutions in HIV-1 integrase.
    Quashie PK; Mesplède T; Han YS; Veres T; Osman N; Hassounah S; Sloan RD; Xu HT; Wainberg MA
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6223-35. PubMed ID: 24080645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity.
    Mesplède T; Osman N; Wares M; Quashie PK; Hassounah S; Anstett K; Han Y; Singhroy DN; Wainberg MA
    J Antimicrob Chemother; 2014 Oct; 69(10):2733-40. PubMed ID: 24917583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug resistance in children and adolescents with HIV in Panama.
    Ventosa-Cubillo J; Pinzón R; González-Alba JM; Estripeaut D; Navarro ML; Holguín Á
    J Antimicrob Chemother; 2023 Feb; 78(2):423-435. PubMed ID: 36454248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High prevalence of virological failure and HIV drug mutations in a first-line cohort of Malawian children.
    Huibers MHW; Moons P; Cornelissen M; Zorgdrager F; Maseko N; Gushu MB; Iwajomo OH; Boele van Hensbroek M; Calis JCJ
    J Antimicrob Chemother; 2018 Dec; 73(12):3471-3475. PubMed ID: 30169653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort.
    Modica S; Rossetti B; Lombardi F; Lagi F; Maffeo M; D'Autilia R; Pecorari M; Vicenti I; Bruzzone B; Magnani G; Paolucci S; Francisci D; Penco G; Sacchini D; Zazzi M; De Luca A; Di Biagio A
    HIV Med; 2019 Feb; 20(2):137-146. PubMed ID: 30461149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations.
    Winters MA; Lloyd RM; Shafer RW; Kozal MJ; Miller MD; Holodniy M
    PLoS One; 2012; 7(7):e40514. PubMed ID: 22815755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India.
    Karade SK; Ghate MV; Chaturbhuj DN; Kadam DB; Shankar S; Gaikwad N; Gurav S; Joshi R; Sane SS; Kulkarni SS; Kurle SN; Paranjape RS; Rewari BB; Gangakhedkar RR
    Medicine (Baltimore); 2016 Sep; 95(37):e4886. PubMed ID: 27631260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana.
    Moraka NO; Garcia-Broncano P; Hu Z; Ajibola G; Bareng OT; Pretorius-Holme M; Maswabi K; Maphorisa C; Mohammed T; Gaseitsiwe S; VanZyl GU; Kuritzkes DR; Lichterfeld M; Moyo S; Shapiro RL
    AIDS; 2021 Dec; 35(15):2413-2421. PubMed ID: 34324451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure.
    Vandenhende MA; Bellecave P; Recordon-Pinson P; Reigadas S; Bidet Y; Bruyand M; Bonnet F; Lazaro E; Neau D; Fleury H; Dabis F; Morlat P; Masquelier B
    PLoS One; 2014; 9(1):e86771. PubMed ID: 24475178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic Accuracy of Pan-Degenerate Amplification and Adaptation Assay for HIV-1 Drug Resistance Mutation Analysis in Low- and Middle-Income Countries.
    Kouamou V; Manasa J; Katzenstein D; McGregor AM; Ndhlovu CE; Makadzange T
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32522826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort.
    Telele NF; Kalu AW; Gebre-Selassie S; Fekade D; Marrone G; Grossmann S; Neogi U; Tegbaru B; Sönnerborg A
    BMC Infect Dis; 2019 Jul; 19(1):569. PubMed ID: 31262272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of Iran.
    Memarnejadian A; Nikpoor AR; Davoodian N; Kargar A; Mirzadeh Y; Gouklani H
    Intervirology; 2019; 62(2):72-79. PubMed ID: 31311021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line Treatment.
    Kouamou V; Varyani B; Shamu T; Mapangisana T; Chimbetete C; Mudzviti T; Manasa J; Katzenstein D
    AIDS Res Hum Retroviruses; 2020 Jul; 36(7):566-573. PubMed ID: 32138527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO.
    Mboumba Bouassa RS; Mossoro-Kpinde CD; Gody JC; Veyer D; Péré H; Matta M; Robin L; Grésenguet G; Charpentier C; Bélec L
    J Antimicrob Chemother; 2019 Jul; 74(7):2030-2038. PubMed ID: 30891603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.
    Baxter JD; Dunn D; Tostevin A; Marvig RL; Bennedbaek M; Cozzi-Lepri A; Sharma S; Kozal MJ; Gompels M; Pinto AN; Lundgren J;
    HIV Med; 2021 May; 22(5):360-371. PubMed ID: 33369017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.
    Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC
    BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pretreatment HIV drug resistance predicts accumulation of new mutations in ART-naïve Ugandan children.
    Soeria-Atmadja S; Amuge P; Nanzigu S; Bbuye D; Rubin J; Eriksen J; Kekitiinwa A; Obua C; Gustafsson LL; Navér L
    Acta Paediatr; 2020 Dec; 109(12):2706-2716. PubMed ID: 32304595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.